Isabelle Rocher

1.3k total citations · 1 hit paper
20 papers, 968 citations indexed

About

Isabelle Rocher is a scholar working on Epidemiology, Infectious Diseases and Emergency Medical Services. According to data from OpenAlex, Isabelle Rocher has authored 20 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 6 papers in Infectious Diseases and 5 papers in Emergency Medical Services. Recurrent topics in Isabelle Rocher's work include Central Venous Catheters and Hemodialysis (5 papers), Tuberculosis Research and Epidemiology (4 papers) and Nosocomial Infections in ICU (4 papers). Isabelle Rocher is often cited by papers focused on Central Venous Catheters and Hemodialysis (5 papers), Tuberculosis Research and Epidemiology (4 papers) and Nosocomial Infections in ICU (4 papers). Isabelle Rocher collaborates with scholars based in Canada, France and Ivory Coast. Isabelle Rocher's co-authors include Dick Menzies, Chantal Valiquette, Bilkis Vissandjée, Richard Menzies, Élise Fortin, Charles Frenette, Caroline Quach, Paul Brassard, Claude Tremblay and Dorothy Moore and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Hepatology and Biochemical Pharmacology.

In The Last Decade

Isabelle Rocher

20 papers receiving 911 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence of Serious Side Effects from First-Line Antituberculosis Drugs among Patients Treated for Active Tuberculosis

2003 648 citations Chantal Valiquette, Isabelle Rocher et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers

Countries citing papers authored by Isabelle Rocher

Since Specialization

Citations

This map shows the geographic impact of Isabelle Rocher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Rocher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Rocher more than expected).

Fields of papers citing papers by Isabelle Rocher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Rocher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Rocher. The network helps show where Isabelle Rocher may publish in the future.

Co-authorship network of co-authors of Isabelle Rocher

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Rocher. A scholar is included among the top collaborators of Isabelle Rocher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Rocher. Isabelle Rocher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Survey of Infection Control Practices in Hemodialysis Units: Preventing Vascular Access–Associated Bloodstream Infections 2014 ·Infection Control and Hospital Epidemiology ·(unknown), Caroline Quach, (unknown), Élise Fortin, Mohammed Kaouache, Simon Desmeules, Isabelle Rocher, (unknown), Charles Frenette, Claude Tremblay, (unknown)	8
2	A survey of Preventive Measures Used and their Impact on Central Line-Associated Bloodstream Infections (CLABSI) in Intensive Care Units (SPIN-BACC) 2013 ·BMC Infectious Diseases ·(unknown), Isabelle Rocher, Élise Fortin, Patrícia S. Fontela, Mohammed Kaouache, Claude Tremblay, Charles Frenette, Caroline Quach	10
3	Central Line–Associated Bloodstream Infection in Neonatal Intensive Care Units 2013 ·Infection Control and Hospital Epidemiology ·Ana C. Blanchard, Élise Fortin, Isabelle Rocher, Dorothy Moore, Charles Frenette, Claude Tremblay, Caroline Quach	25
4	Healthcare-Associated Bloodstream Infections Secondary to a Urinary Focus The Québec Provincial Surveillance Results 2012 ·Infection Control and Hospital Epidemiology ·Élise Fortin, Isabelle Rocher, Charles Frenette, Claude Tremblay, Caroline Quach	31
5	Surveillance Provinciale des Infections Nosocomiales (SPIN) Program: Implementation of a mandatory surveillance program for central line-associated bloodstream infections 2011 ·American Journal of Infection Control ·Patrícia S. Fontela, Robert W. Platt, Isabelle Rocher, Charles Frenette, Dorothy Moore, Élise Fortin, David L. Buckeridge, Madhukar Pai, Caroline Quach	18
6	Epidemiology of central line–associated bloodstream infections in Quebec intensive care units: A 6-year review 2011 ·American Journal of Infection Control ·Patrícia S. Fontela, Robert W. Platt, Isabelle Rocher, Charles Frenette, Dorothy Moore, Élise Fortin, David L. Buckeridge, Madhukar Pai, Caroline Quach	20
7	The impact of smoking on adherence to treatment for latent tuberculosis infection 2006 ·BMC Public Health ·(unknown), Isabelle Rocher, (unknown), Paul Brassard	47
8	P17.57 Evolution of Clostridium difficile Incidence Rates in Quebec, Canada: Data from a Provincial Prospective Surveillance 2006 ·Journal of Hospital Infection ·Rodica Gilca, Bruno Hubert, Élise Fortin, Charles Frenette, Marie Gourdeau, Vivian G. Loo, Lionel A. Poirier, Colette Gaulin, Isabelle Rocher, R M du Bois, T N Tannenbaum, Marc Dionne	1
9	In closely monitored patients, adherence in the first month predicts completion of therapy for latent tuberculosis infection. 2005 ·PubMed ·Dick Menzies, Marie-Josée Dion, Dárrel P. Francis, (unknown), Isabelle Rocher, Sharyn Mannix, Kevin Schwartzman	21
10	Incidence of Serious Side Effects from First-Line Antituberculosis Drugs among Patients Treated for Active Tuberculosis breakdown → 2003 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Chantal Valiquette, (unknown), (unknown), Isabelle Rocher, Dick Menzies	648
11	Factors associated with compliance in treatment of tuberculosis 1993 ·Tubercle and Lung Disease ·Richard Menzies, Isabelle Rocher, Bilkis Vissandjée	74
12	Hemodynamic and pharmacokinetic study of tertatolol in patients with alcoholic cirrhosis and portal hypertension 1993 ·Journal of Hepatology ·Paul Calès, (unknown), (unknown), Jean‐Pierre Vinel, Hervé Desmorat, Isabelle Rocher, Louis Jung, Saı̈k Urien, (unknown), Jean‐Pierre Pascal	4
13	Stereoselective binding of tertatolol and of 4-hydroxytertatolol to human plasma proteins 1992 ·European Journal of Drug Metabolism and Pharmacokinetics ·G. Bastian, Saı̈k Urien, Françoise Brée, Pascale Jolliet, Isabelle Rocher, (unknown), J.P. Tillement	2
14	Interaction of tertatolol with rifampicin and ranitidine pharmacokinetics and antihypertensive activity 1990 ·Cardiovascular Drugs and Therapy ·Wilhelm Kirch, (unknown), Atef Halabi, Isabelle Rocher, (unknown), Louis Jung	7
15	Structure-Activity Relationships as a Response to the Pharmacological Differences in Beta- Receptor Ligands 1989 ·American Journal of Hypertension ·C Labrid, Isabelle Rocher, (unknown)	8
16	Tertatolol in Chronic Renal Failure: A Pharmacokinetic Study 1989 ·American Journal of Hypertension ·M. Rainfray, Isabelle Rocher, F Mignon, A Meyrier	5
17	Variation in serum binding of tertatolol mediated by disease-induced modification of alpha-acid glycoprotein concentration 1988 ·European Journal of Clinical Pharmacology ·Saı̈k Urien, Didier Morin, Anne Renouard, Isabelle Rocher, J P Tillement	9
18	Binding of indapamide to serum proteins and erythrocytes 1988 ·Biochemical Pharmacology ·Saı̈k Urien, P Riant, Anne Renouard, (unknown), Isabelle Rocher, J.P. Tillement	23
19	Hemodynamic and pharmacokinetic study of propranolol and atenolol in cirrhosis patients. 1985 ·PubMed ·Isabelle Rocher, (unknown), (unknown), Didier Lebrec, (unknown), B Flouvat	4
20	The effect of antacid and aspirin on the bioavailability of isofezolac in man. 1984 ·PubMed ·Isabelle Rocher, (unknown), B Flouvat	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact